Omnicell (OMCL)
(Delayed Data from NSDQ)
$44.62 USD
+1.20 (2.76%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $44.44 -0.18 (-0.40%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Omnicell, Inc. [OMCL]
Reports for Purchase
Showing records 41 - 60 ( 337 total )
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Focus on Advanced Services to Drive Growth and Ongoing Margin Expansion; Remain Overweight
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Big 2Q Beat (as We Outlined and Defended After Competitor Double Downgrade into Print); 3Q Guide in Line, but FY Guidance Raised
Provider: KeyBanc Capital Markets
Analyst: Research Department